Form 4: Aspen Aerogels Director Equity Grant Disclosure
Statement of Changes in Beneficial Ownership
Director Kathleen Kool received an annual equity grant of restricted stock units and stock options as part of Aspen Aerogels' non-employee director compensation policy.
Summary
- Director Kathleen Kool was granted 10,370 Restricted Stock Units (RSUs) on May 13, 2026.
- Director Kathleen Kool was granted 8,706 stock options with an exercise price of $5.40 on May 13, 2026.
- The equity awards are part of the standard annual compensation for non-employee directors.
- The awards vest on the earlier of May 13, 2027, or the day prior to the 2027 annual meeting of stockholders.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding standard director compensation.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
- Standardized compensation structure following established corporate policy.
Negatives
- Dilutive impact of new equity grants on existing shareholders, though standard for corporate governance.
Risks
- Market volatility affecting the future value of granted options and RSUs.
Future Outlook
The equity awards are scheduled to vest in May 2027, contingent upon continued service as a director.
Management Comments
- The grants were issued pursuant to the Issuer's Non-Employee Director Compensation Policy.
Industry Context
StockSavvy.ai notes that this is a routine regulatory disclosure regarding director compensation, common among publicly traded companies to ensure board alignment with long-term shareholder value.
Comparison to Industry Standards
- The use of a mix of RSUs and stock options for director compensation is consistent with standard practices for mid-cap industrial and technology firms.
- Vesting schedules of one year for annual director grants are standard practice in the U.S. market.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Director Kathleen Kool authorized company officers to file Section 16 reports on her behalf. | 2025-09-22 | Administrative efficiency for regulatory compliance. |
Stakeholder Impact
- Minimal impact on shareholders; represents standard director compensation.
Next Steps
- Vesting of equity awards on May 13, 2027.
Key Dates
| Date | Description |
|---|---|
| 2025-09-22 | Date of Power of Attorney execution. |
| 2026-05-13 | Date of equity grant transaction. |
| 2027-05-13 | Vesting date for RSUs and options. |
| 2036-05-13 | Expiration date for stock options. |
Keywords
Aspen Aerogels, ASPN, Form 4, Director Compensation, Equity Grant, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.